ABROCITINIB vs UPADACITINIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
ABROCITINIB vs UPADACITINIB: Safety Overview
| Metric | ABROCITINIB | UPADACITINIB |
|---|---|---|
| Total FAERS Reports | 3,170 | 65,656 |
| Deaths Reported | 57 | 2,406 |
| Death Rate | 1.8% | 3.7% |
| Hospitalizations | 329 | 15,931 |
| Average Patient Age | 48.5 yrs | 57.4 yrs |
| % Female Patients | 53.9% | 71.2% |
| FDA Approval Date | Jan 14, 2022 | Apr 26, 2024 |
| Manufacturer | U.S. Pharmaceuticals | AbbVie Inc. |
| Route | ORAL | ORAL |
| Marketing Status | Prescription | Prescription |